U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878430) titled 'Reducing Risk of Stroke and DementIa in PatientS with COVert CERebrovascular Disease' on March 06.
Brief Summary: The purpose of the DISCOVER study is to pilot acceptable approaches to people with covert cerebrovascular disease (CCD) and their follow-up. This is the first step in designing efficient randomised trials of treatments to reduce the risk of stroke or dementia in people with CCD.
Study Start Date: June, 2025
Study Type: OBSERVATIONAL
Condition:
Covert Cerebrovascular Disease
Intervention:
OTHER: Functional and Cognitive scores
We will collect information about prior neurological symptoms, including prior symptoms ...